Suppr超能文献

预测甲状腺乳头状癌患者的生存情况:在两个当代国家患者队列中比较第七版和第八版美国癌症联合委员会/国际癌症控制联合会分期系统。

Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.

机构信息

1 Duke University School of Medicine, Durham, North Carolina.

2 Duke Cancer Institute , Durham, North Carolina.

出版信息

Thyroid. 2017 Nov;27(11):1408-1416. doi: 10.1089/thy.2017.0306. Epub 2017 Oct 5.

Abstract

BACKGROUND

This study aims to compare the seventh and eighth editions of the American Joint Commission on Cancer/Union for International Cancer Control (AJCC/UICC) tumor, node, metastasis staging system for patients with papillary thyroid cancer (PTC) in two national patient cohorts.

METHODS

Adult PTC patients undergoing surgery were selected from the Surveillance, Epidemiology and End Results (SEER) program (2004-2012) and the National Cancer Database (2004-2012). Staging criteria for the seventh and eighth AJCC/UICC editions were applied separately to each cohort. Survival probabilities were estimated using the Kaplan-Meier method. Multivariable Cox proportional hazards models were used to estimate the association of stage with survival in both settings. The Akaike information criterion was used to assess model performance.

RESULTS

About 23% of patients were downstaged from the seventh to the eighth edition in SEER, while 24% were downstaged in the National Cancer Database. Disease-specific survival (DSS) and overall survival (OS) were significantly related to stage at diagnosis when using both the seventh and eighth editions of the AJCC/UICC staging system (p < 0.001). Patients classified into higher stages (III and IV) in the eighth edition showed a worse prognosis than those classified into similar stages in the seventh edition. After adjustment, PTC stages as defined by both editions were significantly associated with DSS and OS. With respect to both DSS and OS, the eighth edition PTC model appeared to be a better fit to the data (smaller Akaike information criterion values) compared to the seventh edition.

CONCLUSION

Based on these large contemporary national cohorts, the eighth edition AJCC/UICC tumor, node, metastasis classification for PTC is superior to the seventh edition for predicting survival.

摘要

背景

本研究旨在比较美国癌症联合委员会/国际癌症控制联盟(AJCC/UICC)第七版和第八版肿瘤、淋巴结、转移分期系统在两个国家患者队列中用于甲状腺乳头状癌(PTC)患者的情况。

方法

从监测、流行病学和最终结果(SEER)计划(2004-2012 年)和国家癌症数据库(2004-2012 年)中选择接受手术的成年 PTC 患者。分别将第七版和第八版 AJCC/UICC 分期标准应用于每个队列。使用 Kaplan-Meier 方法估计生存概率。使用多变量 Cox 比例风险模型估计在两种情况下分期与生存的关联。使用赤池信息量准则评估模型性能。

结果

在 SEER 中,约 23%的患者从第七版降期至第八版,而在国家癌症数据库中,有 24%的患者降期。当使用 AJCC/UICC 分期系统的第七版和第八版时,疾病特异性生存(DSS)和总体生存(OS)与诊断时的分期显著相关(p<0.001)。在第八版中被分类为更高分期(III 期和 IV 期)的患者比在第七版中被分类为相似分期的患者预后更差。调整后,两个版本定义的 PTC 分期与 DSS 和 OS 显著相关。在 DSS 和 OS 方面,与第七版相比,第八版 PTC 模型似乎更适合数据(赤池信息量准则值较小)。

结论

基于这些大型当代国家队列,第八版 AJCC/UICC 肿瘤、淋巴结、转移分类系统用于预测 PTC 患者的生存情况优于第七版。

相似文献

3
Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system.
Br J Surg. 2019 Jun;106(7):889-897. doi: 10.1002/bjs.11145. Epub 2019 Apr 23.
8
A Comparison of the Seventh and Eighth Editions of the AJCC Staging Systems to Predict Recurrence in Papillary Thyroid Microcarcinoma.
Ann Surg Oncol. 2021 Oct;28(11):6564-6571. doi: 10.1245/s10434-021-09596-6. Epub 2021 Jan 31.

引用本文的文献

1
Thyroid Cancer Staging: Historical Evolution and Analysis From Macrocarcinoma to Microcarcinoma.
Cureus. 2025 Apr 9;17(4):e81972. doi: 10.7759/cureus.81972. eCollection 2025 Apr.
2
Efficacy of postoperative radioactive iodine therapy for patients with low and intermediate risk papillary thyroid carcinoma.
Endocrine. 2025 Feb;87(2):685-696. doi: 10.1007/s12020-024-04046-1. Epub 2024 Sep 23.
4
Disparities in Thyroid Cancer Diagnosis Based on Residence and Distance From Medical Facility.
J Endocr Soc. 2024 Feb 18;8(5):bvae033. doi: 10.1210/jendso/bvae033. eCollection 2024 Mar 12.
7
The number of metastatic lymph nodes optimizes staging in patients aged 55 years or older with papillary thyroid cancer.
Front Endocrinol (Lausanne). 2022 Dec 9;13:1026737. doi: 10.3389/fendo.2022.1026737. eCollection 2022.
10
Analysis of risk factors for lateral lymph node metastasis in papillary thyroid carcinoma: A retrospective cohort study.
World J Otorhinolaryngol Head Neck Surg. 2022 Apr 18;8(3):274-278. doi: 10.1016/j.wjorl.2021.01.002. eCollection 2022 Sep.

本文引用的文献

4
Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer.
Ann Surg Oncol. 2016 Feb;23(2):410-5. doi: 10.1245/s10434-015-4762-2. Epub 2015 Jul 28.
5
Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?
Thyroid. 2015 Oct;25(10):1106-14. doi: 10.1089/thy.2015.0104. Epub 2015 Aug 12.
8
The impact of age and gender on papillary thyroid cancer survival.
J Clin Endocrinol Metab. 2012 Jun;97(6):E878-87. doi: 10.1210/jc.2011-2864. Epub 2012 Apr 10.
9
Reevaluating the prognostic significance of age in differentiated thyroid cancer.
Otolaryngol Head Neck Surg. 2012 Aug;147(2):221-6. doi: 10.1177/0194599812441587. Epub 2012 Mar 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验